Dr. Elise de Souter SRL

Dr. Elise de Souter reported total assets of 483,800 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jun 2026).

Company number (CBE) 0779.839.517 · VAT BE0779839517
8970 Poperinge
active in General medical practice activities (NACE 86210)
operating since 07 Jan 2022 (≈ 4 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Dr. Elise de Souter shows with a free account.

See the score
Profile
SRL since 2022
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result83,975 €
Equity5,707 €
Cash125,555 €
EBITDA118,967 €
Total assets483,800 €
The line marks its sector median: 72.4% (5478 companies).

Change 2022 → 2025: Equity -96 % Total assets +143 %

Accounts of the company itself (not consolidated).

The full file covers 4 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Dr. Elise de Souter's annual accounts

2025202420232022
Net result83,975 €
Equity5,707 €
Cash125,555 €
EBITDA118,967 €
Total assets483,800 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 29 Jun 2026
  • Year ended 31 Dec 2024filed on 03 Jun 2025
  • Year ended 31 Dec 2023filed on 22 Apr 2024
  • Year ended 31 Dec 2022filed on 06 Jul 2023

Dr. Elise de Souter's financial analysis

Management and control of Dr. Elise de Souter

1 active director(s) in the register.

Dr. Elise de Souter's shareholders and holdings →

Dr. Elise de Souter's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0779.839.517
VAT number
BE0779839517
Peppol
Registered · 0208:0779839517 · as of 10 Nov 2026
Legal form
SRL
Incorporated
07 Jan 2022
Registered office
8970 Poperinge
Latest accounts
2025 · filed on 29 Jun 2026
Activity
General medical practice activities (NACE 86210)

Dr. Elise de Souter (SRL) has been based in Poperinge since 2022, active in: general medical practice activities. For 2025, it reports a net profit of 83,975 € and equity of 5,707 €; its revenue is not published. Its solvency stands at 1.2%, below the median of its sector (72.4%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Dr. Elise de Souter

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Dr. Elise de Souter

What is the revenue of Dr. Elise de Souter?

Dr. Elise de Souter files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Dr. Elise de Souter?

In Belgium, the VAT number is the company number prefixed with BE: BE0779839517 for Dr. Elise de Souter, if the company is VAT-registered. Its company number (CBE) is 0779.839.517.

Where is the registered office of Dr. Elise de Souter?

According to the CBE register, the registered office of Dr. Elise de Souter is in 8970 Poperinge.

What is the equity of Dr. Elise de Souter?

At the close of the 2025 financial year, the equity of Dr. Elise de Souter amounts to 5,707 €, a solvency of 1.2% of total assets.

Who manages Dr. Elise de Souter?

The register lists 1 active mandates at Dr. Elise de Souter. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Dr. Elise de Souter

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 16 Aug 2026

No credit card, no commitment.

What each plan unlocks →